CLOs on the Move

Cambrex

www.cambrex.com

 
Cambrex is the leading small molecule company that provides drug substance, drug product and analytical services across the entire drug lifecycle. Enjoy working with our experts to accelerate your small molecule therapeutics into the market.
  • Number of Employees: 1K-5K
  • Annual Revenue: $250-500 Million
  • www.cambrex.com
  • 1 Meadowlands Plaza # 1510
    East Rutherford, NJ USA 07073
  • Phone: 201.804.3000

Executives

Name Title Contact Details
Peter Heller
Assistant General Counsel Profile
Eduardo Uribe
VP of Quality and Regulatory Compliance Profile

Similar Companies

Whitman-Walker Health

Social Media Commenting Policy Welcome! Whitman-Walker maintains social media channels as a service to our supporters who wish to keep updated on news from WWH and possibly share information with one another. We are glad to have you join us! We ...

Verinetics

Verinetics is a company that provides the DispenSecur solution for Opioid Medication Management, which offers better control for controlled substances and integrates into existing pharmacy and patient management practices.

Skinmedica Inc

Skinmedica Inc is a Carlsbad, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Novasite Pharmaceutical

Novasite Pharmaceutical is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.

Ionis Pharmaceuticals

For more than 30 years, Ionis has been the leader in RNA-targeted therapy, pioneering new markets and changing standards of care with its novel antisense technology. Ionis currently has three marketed medicines and a premier late-stage pipeline highlighted by industry-leading cardiovascular and neurological franchises. Our scientific innovation began and continues with the knowledge that sick people depend on us, which fuels our vision of becoming a leading, fully integrated biotechnology company. Our drug discovery platform has served as a springboard for actionable promise and realized hope for patients with unmet needs. We created the first and only approved treatment for children and adults with spinal muscular atrophy as well as the world`s first RNA-targeted therapeutic approved for the treatment of polyneuropathy in adults with hereditary transthyretin amyloidosis.